SCI Homepage SCI Database


 SCI 3rd Annual OTC Derivatives Conference 19th October 2012 New York

 
 

SCI’s 3rd Annual OTC Derivatives Seminar
New York 19th October 2012


Introduction
With regulations about to take effect how are market participants getting to grips with the many varied requirements put their way? Discussion and debate is critical for all sides to fully understand the implications for electronic trading and SEFs, centrally clearing, collateral management, reporting, risk management and client segregation. This conference, through panel debates and workshops, seeks to address these issues and to bring the various stakeholders together for the third in our annual series of OTC Derivatives Conferences in New York. Join us to discuss a wide variety of issues affecting your business.

Click here to take the post conference survey and download the conference presentations

Sponsors:


                                                                    
     



08.30 Opening Remarks
Kenneth A. Kopelman, Partner, Bingham McCutchen Bio

08.35 Keynote Speech
Hilmar Schaumann, Chief Risk Officer, Fortress Investment Group Bio

09.10 Impact of regulations on liquidity and trading in a fragmented swaps market
Daily market depth and liquidity in what is going to be a fragmented electronic swaps market - an unintended result of regulatory reform - is a critical issue for investors. Where is the liquidity going to be and what measures to aggregate liquidity are dealers prepared to offer clients to help central order books? What is the true cost of the derivatives trading lifecycle for investors? How will investors choose between SEFs, FCMs and clearers and what will it take to capture liquidity and market share?
Moderator:
Kenneth A. Kopelman, Bingham McCutchen Bio
Panel:
Talha Chaudhry, ex-MF Global Bio
Chris Crowley, ICE Bio
Chris Ferreri, ICAP Bio
Suellen Galish, Javelin Capital Markets Bio

10.10 Break

10:30 Client Segregation & LSOC
Is LSOC sufficient for the OTC markets and would it have prevented client losses connected to the collapse of MF Global and Peregrine Financial? What other models are workable, such as the CME’s plan to act as custodian? The reputation in the futures industry has been one of few such losses but recent bankruptcies have changed that; were participants just lucky and if so what measures will the sell-side be prepared to adopt to protect client funds?
Moderator:
Miki Navazio Bio
Panel:
Corry Bazley, ICE Clear Credit Bio
Bob Burke, Bank of America Merrill Lynch Bio
Mariam Rafi, Citi Bio
Sasha Rozenberg, CME Bio
James Wallin, Alliance Bernstein Bio

11.30 Break

11.45 Central Clearing & The Broker
The proposal for direct investor access to CCPs has prompted concerns over anonymity, fungibility and fair competition, and regulations are still open to interpretation. Will the costs outweigh the benefits for smaller brokers and their customers? Dodd-Frank attempts to outlaw discounted execution for clearing businesses; how will intermediaries build a workable business model? Will access to CCPs be fair and open to all? The clearing roadmap remains unclear and many investors anticipate further changes and delays in regulations; is anyone in a hurry to clear?
Moderator:
Anna Pinedo, Morrison & Foerster Bio
Panel includes:
Sam Ely, Gamma Derivatives Bio 
John Guthrie, BNY Mellon Bio
Dave Olsen, JP Morgan Bio
Paul Rowady, Tabb Group

12.45 Lunch

13.30 Collateral Management & Risk Management of non CCP-cleared trades.
New forms of collateral are being accepted by clearing houses but the requirement for high quality collateral is still onerous. How can you determine the most efficient management of both collateral and its velocity? How should counterparties be managing the collateral and counterparty risks of their portfolios and hedges, and dealing with the less liquid and more complex trades that won’t be cleared centrally? How will such non-centrally cleared positions be defined?
Workshop: Interactive presentation with Q&A
Hosts: (tba)

14.30 Trade Reporting
Regulations demand that all OTC derivatives and any novations are reported to trade repositories within a strict timeframe. What do market participants need to consider whilst implementing this requirement? Is anyone ready to comply?
Workshop: Interactive presentation with Q&A
Host: Mark Bramante, DTCC Bio

15.45 - 16.15 Coffee & Close

 




 

 A selection of delegates who attended the SCI 2nd Annual OTC Derivatives Seminar, October 2011:
 
First Name Surname Company Jobtitle
Tunde Aboyade-Cole Chartered Capital  President/CEO
Mesbah Ahmed TD Securities USA  Director
Obi Akunwafor OppenheimerFunds Director
Armand Aponte ING Investment Management Counsel
Alexander Avtsin Aladdin Capital Portfolio Manager
Mari   Baca New York Fed
Wais Baryalai Christofferson Robb & Co. Associate Director
Greg Bazarian Hutchin Hill Ops Supervisor
Corry  Bazley ICE
Unmesh Bhide JP Morgan
Grant Biggar Creditex
Mike  Black Javelin Capital Markets
Jasper Brice HSBC Senior Examiner
Mary Brown Principal Global Investors  Head of Research
Jamie Cawley Javelin Capital Markets
Yin Chan Swiss Re Consultant
Jane Chan TD Securities USA LLC Consultant
Swan Chang Forum Asset Management Inc.  COO/CFO
Geoffroy Charles BNP Paribas Director
Waqas Chaudhry Christofferson Robb & Co. Associate Director
Kathryn Chen Federal Reserve Bank of NY Assistant Vice President
Everett Cheng BNP Paribas Director
Jagdish Chhabria IBM Senior Managing Consultant
Evelyn Cho Christofferson, Robb & Co. Associate
Jane Choy AllianceBernstein VP
Richard Claiden Primus Guaranty CEO
Kyle Cleeton Lepercq Lynx Research Analyst
Camille Clingan AllianceBernstein AVP
Chris Cococcia Deutsche Bank Director, Hedge Fund Consulting
Sean Cort Fortress CAO
Mohit Dayal FINRA Managing Dir, Fin Economist
Pat   Defrancesco Creditex
Sonja DeLange MKP Capital Operations
Cole Dolinger Federated Invetsors Derivatives Analyst
Pamela Domanski UBS Director
Elaine Duff J.P.Morgan
Amr El-Sabbagh FINRA Director
Karel Engelen ISDA
Aletta Erk JPMorgan Manager CVA credit risk
Yeta Eweka Primus Financial Products, LLC Director of Operations and Technology
Irene Falkovich BNY Mellon VP
Jonathan  Ferguson Credit Suisse
Eugene Fialkovskiy King Street Capital Management Assistant General Counsel
Ronald  Filler N.Y. Law School
Sinead Fitzgerald General Electric Middle Office
Nataliya Frost CME  Risk Business Analyst
Nadya Frukter Hudson Bay Capital Management CFO
Rajan Gadkari BNY Mellon Managing Director
Diego Garcia CME Group
Steven Gilson Visium Asset Management Director of Operations
Paul Goldberg Fir Tree Partners Middle Office
Jacqueline Granados Credit Suisse Negotiator General Counsel Division
Claudia Green Fermat Capital Management General Counsel
James Griffiths Bank of America Merrill Lynch Sales & Marketing
Chris Hansen-Nelson TD Securities VP & Director
Martin Helm Syncope LLC Portfolio Manager
Moritz Hilf DFG Investment Advisers Portfolio Manager
Paul Homsy Cutwater Asset Management Analyst
Max Horn Stone Harbor Investment Partners Quantitative Research
Simon Hylson-Smith  Tradeweb
Isabelle Jacobs UBS Analyst
Mark Josling Creditex
Mark Kahn Actualize Consulting Director
Kapil Khetan New York University
Richard Kim Seer Capital Management LP Chief Operating Officer
Lance  Kisling JP Morgan
Mike  Kondas S&P Indices 
Ken Kopelman Bingham McCutchen
Stephen Kruft Credit Suisse Director
Stephanie Kumar Fitch Ratings Ad manager
Kent Kurtz HSBC Managing Director
Ed Labrenz Par-Four Investment CFO
Edward Lehmann Citi Director
Harrison Lei Bank Of America Director
Rober  Leonard Bingham
Julius Levitas Hutchin Hill Operations Supervisor
Todd Lurie MetLife Assistant General Counsel
Jeff Maron GFI
Jessica McAnneny BlackRock Vice President
Timothy McKenna
Amanda  Meatto Creditex
David  Miller Credit Suisse CEO
Frank  Mineo CME Group
Jean Mra Morgan Stanley associate
Nancy Musuraca New York Life Investments 2nd VP
Wendy Ng New York Fed
Matt Ober WorldQuant Research
Dermot O'Brien King Street Capital Management Derivative Operations Manager
Sharon Oconnor General Electric Middle Office Derivative Analyst
John Olert Group Managing Director
John O'Meara InnerHarbor Advisors MP
James  Parascandola M.F.Global
Christina Patoir Fortress Investment Group Market Data Analyst
Jennifer Peve CME
Jackie Polak LBBW VP
Rajendren Ponniah Citigroup Risk Manager
George  Pratt Claren Road
Mariam  Rafi Citi
Gregg Rapaport DTCC
Eric Reichenberg GlobeOp Financial Services Global Director-Valuations
James  Rieger S&P Indices 
Stephen Robinson DW Investment Management Quantitative Analyst
Darren Rose Federal Reserve Bank of NY Business Analyst
Darren Rose
Christina Saber HSBC Counsel
Nader  Salehi Bingham
Jasmit Sandhu CMA Sales
James Sarvis Morgan Stanley Executive Director
Stephen Scarpulla Fir Tree Partners Operations Vice President
Hilmar Schaumann Fortress Investment Group
Joshua Schwab PAAMCO Manager
Jean Shedlock BlackRock Managing Director
Mickey Shemi Christofferson, Robb & Co. Director
Jason Shuey Brigade Capital Senior Software Engineer
David Sims Fortress Counsel
Adam singer Ambac counsel
Charles Smith DW Investment Management Quantitative Analyst
Shelley  Spaner Deutsche Bank
Micah Spiegel Sancus Capital Management  Controller
Jeff Stern Stroock Stroock and Lavan
Laura Strache Sandell Asset Management Corp. Managing Director
Rebecca Strutton New York Life Investments Director, Associate General Counsel
Paul Sutters Investance Manager
Vincent Tang Nomura Executive Director
Thomas Taylor GRX Capital SVP
Albert Tew II Sumitomo Trust and Banking Co. Vice President
Richard Tilghman Ramirez & Co. svp
Tomas Tjarnberg Citi Director
James Tramposch J.P. Morgan Vice President
Iris Trotman TD Securities (USA)  Senior Project Manager
Julia Troyan Price Waterhouse Coopers  Manager
Walt Tsin Seer Capital Management CFO
Alex Urdea Solus LP Managing Director
Vassos Vassiliou RiversideCredit Inv. Corp. Managing Partner
Matthew Vodola Brigade Capital Management Associate
Kathy Wheadon DCI Head of Operations
Kyle  White MarketAxess
Takayoshi Wiesner Mizuho Corporate Bank AVP
Nish Wijerathna Avenue Capital Group cto
Panos Xythalis CME  Associate Director
Patrick Yoon Mizuho Corporate Bank Officer
Mengdan Yu Citi Market Risk Manager
Neal Zephyrin CIC VP Risk Management
Ali Zeshan JP Morgan  Vice President
Steve Zhu PAMCO Analyst

And some of their comments:
Overall definitely useful; some new information, some I knew, but always good to get another angle on things
Regulatory speaker was awesome - very good how she differentiated herself from the politicians
Very good from a competitive standpoint; glad I attended
Valuable event - enjoyed it - lots yet to be learned in the area
Helped clear a lot of things up and helped us prepare where we need to be for central clearing
Very educational on cds central clearing
Well organised - thanks
Helpful, good to re-iterate discussions and meet with colleagues to see what's going on
Good for regulatory coverage, and information on moving to central clearing was useful
Idea was fantastic - execution was good; networking was very good
Very informative and detailed
Very good networking opportunities
Central clearing panel was excellently run
Always great events - love being able to pop out to SCI events in the city - agenda usually very current
Good clearing participants and buy side perspective was useful
The conference was focussed and the segments were substantive. I got what I wanted out of this event
Regulatory perspective was excellent, and most speakers spoke with authority
Clearing & Regulatory sessions were very useful - this is why I attended
Particularly valuable to meet with the banks clearing CDS trades
Good - wanted to attend as I needed an idea of what regulators were thinking


And a selection of related article
The Economist
Open deck
Shifting more derivatives trades into the open creates opportunities






  Categories Please read our Terms and ConditionsPrivacy Policy  before using the site.   FAQ Copyright © SCI 2006-2013